Wenwen Zhang

ORCID: 0000-0003-1285-3118 · 9 papers in corpus
review 2026
International journal of women's health ·doi:10.2147/ijwh.s636972

This narrative review first summarizes current treatment strategies and postoperative prevention measures for intrauterine adhesions (IUAs), then discusses prognostic factors associated with pregnancy outcomes and recent advances in predict…

meta-analysis 2025
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-08091-7

The incidence of malignant tumors continues to grow. Still, with the rapid development of various diagnostic and therapeutic techniques, the survival rate of malignant tumors has been improved, and the increased survival rate has introduced…

review 2025
Molecular medicine reports ·doi:10.3892/mmr.2024.13422

Endometriosis (EM) is a chronic inflammatory disease that is one of the most common causes of gynecological systemic lesions in women before menopause. The most representative histological feature of EM is that the endometrium appears outsi…

review 2024
BMC women's health ·doi:10.1186/s12905-024-03316-4

BACKGROUND: To explore the clinical characteristics of ovarian Brenner tumors and provide some basis for the treatment regimen of ovarian Brenner tumors. METHODS: A retrospective analysis of the pathology database of surgical specimens at …

case-report 2024
Frontiers in oncology ·doi:10.3389/fonc.2024.1298109

Multiple primary malignant neoplasms are a rare gynecologic malignancy; particularly, cases originating from the heterologous organs, such as the ovary and cervix. Here, we report a case of two primary malignant neoplasms in a patient who h…

other 2023
Technology in cancer research & treatment ·doi:10.1177/15330338231184995

BACKGROUND: According to previous literatures, plasma thioredoxin reductase (TrxR) level was significantly elevated in various malignant tumors and serve as a potential biomarker for diagnosis and prognostic prediction. However, there is li…

2021
·doi:10.21203/rs.3.rs-342433/v1

Abstract Objective: Our objective was to investigate the upregulated expression of ribonucleotide reductase M2 (RRM2) in the ectopic endometrium (EC) of ovarian endometriosis (OE) patients that may indicate malignant transformation. RRM2 ma…

other 2021
BioMed research international ·doi:10.1155/2021/9923434

Gynecological malignancies are tumors of the female reproductive system, mainly cervical cancer, endometrial cancer, and ovarian cancer. Endometrial cancer (EC) is the most common gynecological malignant tumor in developed countries. The ai…

other 2021
Advances in therapy ·doi:10.1007/s12325-021-01888-3

INTRODUCTION: A large number of epidemiological studies have revealed that women with endometriosis (EMS) have a higher risk of developing endometriosis-associated ovarian cancer (EAOC). At present, there are few studies on predicting the m…